George Daaboul
CEO

Everest Biolabs provides tools for extracellular vesicle (EV) research, focusing on isolation and analysis workflows. The company offers automated instruments, high-performance size exclusion chromatography (SEC) columns, and ELISA kits for EV quantification and purity assessment. These solutions aim to increase productivity and accelerate research translation in the EV field.
Extracellular vesicle (EV) research is often hindered by inefficient and inconsistent isolation and analysis methods. Traditional techniques are labor-intensive, lack reproducibility, and require large sample volumes, impeding progress in clinical applications.
Everest Biolabs offers automated, high-throughput solutions for EV isolation and analysis, addressing the limitations of conventional methods. Their Ascent instrument automates size-exclusion chromatography (SEC), enabling parallel processing of up to eight columns and precise fraction collection. Paired with Apex SEC Columns, the system delivers reproducible EV isolation with minimal variability. For downstream analysis, Atlas ELISA Kits allow direct EV quantification and purity assessment from biofluids or SEC fractions, eliminating the need for pre-concentration or purification. The Atlas ELISA Reader provides rapid absorbance measurements for efficient data acquisition.
The primary audience includes researchers in the extracellular vesicle field seeking to accelerate the translation of their work into clinical applications.